Kevin Sha

Global life science & healthcare investments and business expansion

• Deal sourcing, evaluation and execution of early stage US biotech investments • Networking and building relationships with prominent US biotech VCs to secure high profile investment opportunities • Business development related activities with academia, institutions, and industry for licensing in/out assets

• Develop and expand overseas network and business relationships • Initiate and execute partnerships and strategic alliance management with global pharmaceutical and biotechnology companies for licensing in/out activities • Vendor sourcing and identifying collaboration initiatives • Setup, manage and negotiate agreements and contracts for partnerships as well as global CROs, CDMOs, vendors and consultant services for development activities • Collaborate and lead communication and discussions with cross-functional drug development experts to drive development of drug candidates • Scientific, clinical and market review and assessment and competitive intelligence to support development strategies

• Primary and secondary research, analysis and client reporting of market landscape, treatment pathway and pricing strategy for launch of an originator product in SEA markets • Drafted an insight paper on the pharmaceutical market, trends and impact on MNCs of the Philippines market

• Participated in initial talks for potential partnership investments and follow-up correspondences for pipeline projects • Secondary research and presentation on biosimilar regulations and updates, sales forecasting, competitive landscape, key findings and recommendations for major markets

• Project lead for a multi-hospital site tissue sample and clinical database pancreatic cancer study • Development and implementation of a new Medidata database for pancreatic cancer across multiple hospital sites • Trial, data and site coordination and management of early phase oncology clinical studies for solid tumors and lymphomas • Clinical study experience include small molecules, biologics and immunotherapy • Working knowledge of ICH-GCP, RECIST 1.1, CTCAE v4, TCPS 2, FDA 21 CFR, clinical research ethics, clinical data management and EDC systems (Medidata, Oracle, InForm)

Thesis: Characterization of valproic acid (Depakene)-initiated homologous recombination

Toxicology Specialist, Life Science Major, Physiology Minor

MBA Exchange Program: September 2015 - December 2015